Cargando…

The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol

OBJECTIVE: To present the development of a novel upper extremity (UE) treatment and assess how it was delivered in the Critical Periods After Stroke Study (CPASS), a phase II randomized controlled trial (RCT). DESIGN: Secondary analysis of data from the RCT. SETTING: Inpatient and outpatient setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Jessica, Geed, Shashwati, Mitchell, Abigail, Brady, Kathaleen P., Giannetti, Margot L., Dromerick, Alexander W., Edwards, Dorothy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517370/
https://www.ncbi.nlm.nih.gov/pubmed/37744191
http://dx.doi.org/10.1016/j.arrct.2023.100282
_version_ 1785109305362481152
author Barth, Jessica
Geed, Shashwati
Mitchell, Abigail
Brady, Kathaleen P.
Giannetti, Margot L.
Dromerick, Alexander W.
Edwards, Dorothy F.
author_facet Barth, Jessica
Geed, Shashwati
Mitchell, Abigail
Brady, Kathaleen P.
Giannetti, Margot L.
Dromerick, Alexander W.
Edwards, Dorothy F.
author_sort Barth, Jessica
collection PubMed
description OBJECTIVE: To present the development of a novel upper extremity (UE) treatment and assess how it was delivered in the Critical Periods After Stroke Study (CPASS), a phase II randomized controlled trial (RCT). DESIGN: Secondary analysis of data from the RCT. SETTING: Inpatient and outpatient settings the first year after stroke. PARTICIPANTS: Of the 72 participants enrolled in CPASS (N=72), 53 were in the study groups eligible to receive the treatment initiated at ≤30 days (acute), 2-3 months (subacute), or ≥6 months (chronic) poststroke. Individuals were 65.1±10.5 years of age, 55% were women, and had mild to moderate UE motor capacity (Action Research Arm Test=17.2±14.3) at baseline. INTERVENTION: The additional 20 hours of treatment began using the Activity Card Sort (ACS), a standardized assessment of activities and participation after stroke, to identify UE treatment goals selected by the participants that were meaningful to them. Treatment activities were broken down into smaller components from a standardized protocol and process that operationalized the treatments essential elements. MAIN OUTCOME MEASURE(S): Feasibility of performing the treatment in a variety of clinical settings in an RCT and contextual factors that influenced adherence. RESULTS: A total of 49/53 participants fully adhered to the CPASS treatment. The duration and location of the treatment sessions and the UE activities practiced during therapy are presented for the total sample (n=49) and per study group as an assessment of feasibility and the contextual factors that influenced adherence. CONCLUSIONS: The CPASS treatment and therapy goals were explicitly based on the meaningful activities identified by the participants using the ACS as a treatment planning tool. This approach provided flexibility to customize UE motor therapy without sacrificing standardization or quantification of the data regardless of the location and UE impairments of participants within the first year poststroke.
format Online
Article
Text
id pubmed-10517370
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105173702023-09-24 The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol Barth, Jessica Geed, Shashwati Mitchell, Abigail Brady, Kathaleen P. Giannetti, Margot L. Dromerick, Alexander W. Edwards, Dorothy F. Arch Rehabil Res Clin Transl Original Research OBJECTIVE: To present the development of a novel upper extremity (UE) treatment and assess how it was delivered in the Critical Periods After Stroke Study (CPASS), a phase II randomized controlled trial (RCT). DESIGN: Secondary analysis of data from the RCT. SETTING: Inpatient and outpatient settings the first year after stroke. PARTICIPANTS: Of the 72 participants enrolled in CPASS (N=72), 53 were in the study groups eligible to receive the treatment initiated at ≤30 days (acute), 2-3 months (subacute), or ≥6 months (chronic) poststroke. Individuals were 65.1±10.5 years of age, 55% were women, and had mild to moderate UE motor capacity (Action Research Arm Test=17.2±14.3) at baseline. INTERVENTION: The additional 20 hours of treatment began using the Activity Card Sort (ACS), a standardized assessment of activities and participation after stroke, to identify UE treatment goals selected by the participants that were meaningful to them. Treatment activities were broken down into smaller components from a standardized protocol and process that operationalized the treatments essential elements. MAIN OUTCOME MEASURE(S): Feasibility of performing the treatment in a variety of clinical settings in an RCT and contextual factors that influenced adherence. RESULTS: A total of 49/53 participants fully adhered to the CPASS treatment. The duration and location of the treatment sessions and the UE activities practiced during therapy are presented for the total sample (n=49) and per study group as an assessment of feasibility and the contextual factors that influenced adherence. CONCLUSIONS: The CPASS treatment and therapy goals were explicitly based on the meaningful activities identified by the participants using the ACS as a treatment planning tool. This approach provided flexibility to customize UE motor therapy without sacrificing standardization or quantification of the data regardless of the location and UE impairments of participants within the first year poststroke. Elsevier 2023-07-24 /pmc/articles/PMC10517370/ /pubmed/37744191 http://dx.doi.org/10.1016/j.arrct.2023.100282 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Barth, Jessica
Geed, Shashwati
Mitchell, Abigail
Brady, Kathaleen P.
Giannetti, Margot L.
Dromerick, Alexander W.
Edwards, Dorothy F.
The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title_full The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title_fullStr The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title_full_unstemmed The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title_short The Critical Period After Stroke Study (CPASS) Upper Extremity Treatment Protocol
title_sort critical period after stroke study (cpass) upper extremity treatment protocol
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517370/
https://www.ncbi.nlm.nih.gov/pubmed/37744191
http://dx.doi.org/10.1016/j.arrct.2023.100282
work_keys_str_mv AT barthjessica thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT geedshashwati thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT mitchellabigail thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT bradykathaleenp thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT giannettimargotl thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT dromerickalexanderw thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT edwardsdorothyf thecriticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT barthjessica criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT geedshashwati criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT mitchellabigail criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT bradykathaleenp criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT giannettimargotl criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT dromerickalexanderw criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol
AT edwardsdorothyf criticalperiodafterstrokestudycpassupperextremitytreatmentprotocol